Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial
Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective H...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Baeten, Jared M [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model - Berhane, S. ELSEVIER, 2016, New York, NY |
|---|---|
| Übergeordnetes Werk: |
volume:14 ; year:2014 ; number:11 ; pages:1055-1064 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/S1473-3099(14)70937-5 |
|---|
| Katalog-ID: |
ELV027904164 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV027904164 | ||
| 003 | DE-627 | ||
| 005 | 20230623191754.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1473-3099(14)70937-5 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014004000028.pica |
| 035 | |a (DE-627)ELV027904164 | ||
| 035 | |a (ELSEVIER)S1473-3099(14)70937-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.44 |2 bkl | ||
| 100 | 1 | |a Baeten, Jared M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial |
| 264 | 1 | |c 2014 | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective HIV-1 treatment, more than one agent might not be required for effective prophylaxis. We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP. | ||
| 700 | 1 | |a Donnell, Deborah |4 oth | |
| 700 | 1 | |a Mugo, Nelly R |4 oth | |
| 700 | 1 | |a Ndase, Patrick |4 oth | |
| 700 | 1 | |a Thomas, Katherine K |4 oth | |
| 700 | 1 | |a Campbell, James D |4 oth | |
| 700 | 1 | |a Wangisi, Jonathan |4 oth | |
| 700 | 1 | |a Tappero, Jordan W |4 oth | |
| 700 | 1 | |a Bukusi, Elizabeth A |4 oth | |
| 700 | 1 | |a Cohen, Craig R |4 oth | |
| 700 | 1 | |a Katabira, Elly |4 oth | |
| 700 | 1 | |a Ronald, Allan |4 oth | |
| 700 | 1 | |a Tumwesigye, Elioda |4 oth | |
| 700 | 1 | |a Were, Edwin |4 oth | |
| 700 | 1 | |a Fife, Kenneth H |4 oth | |
| 700 | 1 | |a Kiarie, James |4 oth | |
| 700 | 1 | |a Farquhar, Carey |4 oth | |
| 700 | 1 | |a John-Stewart, Grace |4 oth | |
| 700 | 1 | |a Kidoguchi, Lara |4 oth | |
| 700 | 1 | |a Coombs, Robert W |4 oth | |
| 700 | 1 | |a Hendrix, Craig |4 oth | |
| 700 | 1 | |a Marzinke, Mark A |4 oth | |
| 700 | 1 | |a Frenkel, Lisa |4 oth | |
| 700 | 1 | |a Haberer, Jessica E |4 oth | |
| 700 | 1 | |a Bangsberg, David |4 oth | |
| 700 | 1 | |a Celum, Connie |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Berhane, S. ELSEVIER |t Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |d 2016 |g New York, NY |w (DE-627)ELV013808834 |
| 773 | 1 | 8 | |g volume:14 |g year:2014 |g number:11 |g pages:1055-1064 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S1473-3099(14)70937-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_26 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_70 | ||
| 936 | b | k | |a 44.44 |j Parasitologie |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 14 |j 2014 |e 11 |h 1055-1064 |g 10 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
j m b jm jmb |
|---|---|
| matchkey_str |
baetenjaredmdonnelldeborahmugonellyrndas:2014----:igegntnfvressobntoetiiaielseooifrrepsrpohlxsohvaqiiinnpaef |
| hierarchy_sort_str |
2014 |
| bklnumber |
44.44 |
| publishDate |
2014 |
| allfields |
10.1016/S1473-3099(14)70937-5 doi GBVA2014004000028.pica (DE-627)ELV027904164 (ELSEVIER)S1473-3099(14)70937-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.44 bkl Baeten, Jared M verfasserin aut Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial 2014 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective HIV-1 treatment, more than one agent might not be required for effective prophylaxis. We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP. Donnell, Deborah oth Mugo, Nelly R oth Ndase, Patrick oth Thomas, Katherine K oth Campbell, James D oth Wangisi, Jonathan oth Tappero, Jordan W oth Bukusi, Elizabeth A oth Cohen, Craig R oth Katabira, Elly oth Ronald, Allan oth Tumwesigye, Elioda oth Were, Edwin oth Fife, Kenneth H oth Kiarie, James oth Farquhar, Carey oth John-Stewart, Grace oth Kidoguchi, Lara oth Coombs, Robert W oth Hendrix, Craig oth Marzinke, Mark A oth Frenkel, Lisa oth Haberer, Jessica E oth Bangsberg, David oth Celum, Connie oth Enthalten in Elsevier Berhane, S. ELSEVIER Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model 2016 New York, NY (DE-627)ELV013808834 volume:14 year:2014 number:11 pages:1055-1064 extent:10 https://doi.org/10.1016/S1473-3099(14)70937-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 44.44 Parasitologie Medizin VZ AR 14 2014 11 1055-1064 10 045F 610 |
| spelling |
10.1016/S1473-3099(14)70937-5 doi GBVA2014004000028.pica (DE-627)ELV027904164 (ELSEVIER)S1473-3099(14)70937-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.44 bkl Baeten, Jared M verfasserin aut Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial 2014 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective HIV-1 treatment, more than one agent might not be required for effective prophylaxis. We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP. Donnell, Deborah oth Mugo, Nelly R oth Ndase, Patrick oth Thomas, Katherine K oth Campbell, James D oth Wangisi, Jonathan oth Tappero, Jordan W oth Bukusi, Elizabeth A oth Cohen, Craig R oth Katabira, Elly oth Ronald, Allan oth Tumwesigye, Elioda oth Were, Edwin oth Fife, Kenneth H oth Kiarie, James oth Farquhar, Carey oth John-Stewart, Grace oth Kidoguchi, Lara oth Coombs, Robert W oth Hendrix, Craig oth Marzinke, Mark A oth Frenkel, Lisa oth Haberer, Jessica E oth Bangsberg, David oth Celum, Connie oth Enthalten in Elsevier Berhane, S. ELSEVIER Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model 2016 New York, NY (DE-627)ELV013808834 volume:14 year:2014 number:11 pages:1055-1064 extent:10 https://doi.org/10.1016/S1473-3099(14)70937-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 44.44 Parasitologie Medizin VZ AR 14 2014 11 1055-1064 10 045F 610 |
| allfields_unstemmed |
10.1016/S1473-3099(14)70937-5 doi GBVA2014004000028.pica (DE-627)ELV027904164 (ELSEVIER)S1473-3099(14)70937-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.44 bkl Baeten, Jared M verfasserin aut Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial 2014 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective HIV-1 treatment, more than one agent might not be required for effective prophylaxis. We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP. Donnell, Deborah oth Mugo, Nelly R oth Ndase, Patrick oth Thomas, Katherine K oth Campbell, James D oth Wangisi, Jonathan oth Tappero, Jordan W oth Bukusi, Elizabeth A oth Cohen, Craig R oth Katabira, Elly oth Ronald, Allan oth Tumwesigye, Elioda oth Were, Edwin oth Fife, Kenneth H oth Kiarie, James oth Farquhar, Carey oth John-Stewart, Grace oth Kidoguchi, Lara oth Coombs, Robert W oth Hendrix, Craig oth Marzinke, Mark A oth Frenkel, Lisa oth Haberer, Jessica E oth Bangsberg, David oth Celum, Connie oth Enthalten in Elsevier Berhane, S. ELSEVIER Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model 2016 New York, NY (DE-627)ELV013808834 volume:14 year:2014 number:11 pages:1055-1064 extent:10 https://doi.org/10.1016/S1473-3099(14)70937-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 44.44 Parasitologie Medizin VZ AR 14 2014 11 1055-1064 10 045F 610 |
| allfieldsGer |
10.1016/S1473-3099(14)70937-5 doi GBVA2014004000028.pica (DE-627)ELV027904164 (ELSEVIER)S1473-3099(14)70937-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.44 bkl Baeten, Jared M verfasserin aut Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial 2014 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective HIV-1 treatment, more than one agent might not be required for effective prophylaxis. We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP. Donnell, Deborah oth Mugo, Nelly R oth Ndase, Patrick oth Thomas, Katherine K oth Campbell, James D oth Wangisi, Jonathan oth Tappero, Jordan W oth Bukusi, Elizabeth A oth Cohen, Craig R oth Katabira, Elly oth Ronald, Allan oth Tumwesigye, Elioda oth Were, Edwin oth Fife, Kenneth H oth Kiarie, James oth Farquhar, Carey oth John-Stewart, Grace oth Kidoguchi, Lara oth Coombs, Robert W oth Hendrix, Craig oth Marzinke, Mark A oth Frenkel, Lisa oth Haberer, Jessica E oth Bangsberg, David oth Celum, Connie oth Enthalten in Elsevier Berhane, S. ELSEVIER Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model 2016 New York, NY (DE-627)ELV013808834 volume:14 year:2014 number:11 pages:1055-1064 extent:10 https://doi.org/10.1016/S1473-3099(14)70937-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 44.44 Parasitologie Medizin VZ AR 14 2014 11 1055-1064 10 045F 610 |
| allfieldsSound |
10.1016/S1473-3099(14)70937-5 doi GBVA2014004000028.pica (DE-627)ELV027904164 (ELSEVIER)S1473-3099(14)70937-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.44 bkl Baeten, Jared M verfasserin aut Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial 2014 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective HIV-1 treatment, more than one agent might not be required for effective prophylaxis. We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP. Donnell, Deborah oth Mugo, Nelly R oth Ndase, Patrick oth Thomas, Katherine K oth Campbell, James D oth Wangisi, Jonathan oth Tappero, Jordan W oth Bukusi, Elizabeth A oth Cohen, Craig R oth Katabira, Elly oth Ronald, Allan oth Tumwesigye, Elioda oth Were, Edwin oth Fife, Kenneth H oth Kiarie, James oth Farquhar, Carey oth John-Stewart, Grace oth Kidoguchi, Lara oth Coombs, Robert W oth Hendrix, Craig oth Marzinke, Mark A oth Frenkel, Lisa oth Haberer, Jessica E oth Bangsberg, David oth Celum, Connie oth Enthalten in Elsevier Berhane, S. ELSEVIER Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model 2016 New York, NY (DE-627)ELV013808834 volume:14 year:2014 number:11 pages:1055-1064 extent:10 https://doi.org/10.1016/S1473-3099(14)70937-5 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 44.44 Parasitologie Medizin VZ AR 14 2014 11 1055-1064 10 045F 610 |
| language |
English |
| source |
Enthalten in Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model New York, NY volume:14 year:2014 number:11 pages:1055-1064 extent:10 |
| sourceStr |
Enthalten in Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model New York, NY volume:14 year:2014 number:11 pages:1055-1064 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Parasitologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |
| authorswithroles_txt_mv |
Baeten, Jared M @@aut@@ Donnell, Deborah @@oth@@ Mugo, Nelly R @@oth@@ Ndase, Patrick @@oth@@ Thomas, Katherine K @@oth@@ Campbell, James D @@oth@@ Wangisi, Jonathan @@oth@@ Tappero, Jordan W @@oth@@ Bukusi, Elizabeth A @@oth@@ Cohen, Craig R @@oth@@ Katabira, Elly @@oth@@ Ronald, Allan @@oth@@ Tumwesigye, Elioda @@oth@@ Were, Edwin @@oth@@ Fife, Kenneth H @@oth@@ Kiarie, James @@oth@@ Farquhar, Carey @@oth@@ John-Stewart, Grace @@oth@@ Kidoguchi, Lara @@oth@@ Coombs, Robert W @@oth@@ Hendrix, Craig @@oth@@ Marzinke, Mark A @@oth@@ Frenkel, Lisa @@oth@@ Haberer, Jessica E @@oth@@ Bangsberg, David @@oth@@ Celum, Connie @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV013808834 |
| dewey-sort |
3610 |
| id |
ELV027904164 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV027904164</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623191754.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1473-3099(14)70937-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014004000028.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV027904164</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1473-3099(14)70937-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.44</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Baeten, Jared M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective HIV-1 treatment, more than one agent might not be required for effective prophylaxis. We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Donnell, Deborah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mugo, Nelly R</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ndase, Patrick</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomas, Katherine K</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Campbell, James D</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wangisi, Jonathan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tappero, Jordan W</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bukusi, Elizabeth A</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohen, Craig R</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Katabira, Elly</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ronald, Allan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tumwesigye, Elioda</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Were, Edwin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fife, Kenneth H</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kiarie, James</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Farquhar, Carey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">John-Stewart, Grace</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kidoguchi, Lara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Coombs, Robert W</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hendrix, Craig</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marzinke, Mark A</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Frenkel, Lisa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Haberer, Jessica E</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bangsberg, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Celum, Connie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Berhane, S. ELSEVIER</subfield><subfield code="t">Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model</subfield><subfield code="d">2016</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV013808834</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:14</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:1055-1064</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1473-3099(14)70937-5</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.44</subfield><subfield code="j">Parasitologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">14</subfield><subfield code="j">2014</subfield><subfield code="e">11</subfield><subfield code="h">1055-1064</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Baeten, Jared M |
| spellingShingle |
Baeten, Jared M ddc 610 bkl 44.44 Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial |
| authorStr |
Baeten, Jared M |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV013808834 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.44 bkl Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial |
| topic |
ddc 610 bkl 44.44 |
| topic_unstemmed |
ddc 610 bkl 44.44 |
| topic_browse |
ddc 610 bkl 44.44 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d d dd n r m nr nrm p n pn k k t kk kkt j d c jd jdc j w jw j w t jw jwt e a b ea eab c r c cr crc e k ek a r ar e t et e w ew k h f kh khf j k jk c f cf g j s gjs l k lk r w c rw rwc c h ch m a m ma mam l f lf j e h je jeh d b db c c cc |
| hierarchy_parent_title |
Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |
| hierarchy_parent_id |
ELV013808834 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV013808834 |
| title |
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial |
| ctrlnum |
(DE-627)ELV027904164 (ELSEVIER)S1473-3099(14)70937-5 |
| title_full |
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial |
| author_sort |
Baeten, Jared M |
| journal |
Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |
| journalStr |
Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
1055 |
| author_browse |
Baeten, Jared M |
| container_volume |
14 |
| physical |
10 |
| class |
610 610 DE-600 610 VZ 44.44 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Baeten, Jared M |
| doi_str_mv |
10.1016/S1473-3099(14)70937-5 |
| dewey-full |
610 |
| title_sort |
single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for hiv-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial |
| title_auth |
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial |
| abstract |
Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective HIV-1 treatment, more than one agent might not be required for effective prophylaxis. We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP. |
| abstractGer |
Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective HIV-1 treatment, more than one agent might not be required for effective prophylaxis. We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP. |
| abstract_unstemmed |
Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective HIV-1 treatment, more than one agent might not be required for effective prophylaxis. We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_11 GBV_ILN_26 GBV_ILN_40 GBV_ILN_70 |
| container_issue |
11 |
| title_short |
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial |
| url |
https://doi.org/10.1016/S1473-3099(14)70937-5 |
| remote_bool |
true |
| author2 |
Donnell, Deborah Mugo, Nelly R Ndase, Patrick Thomas, Katherine K Campbell, James D Wangisi, Jonathan Tappero, Jordan W Bukusi, Elizabeth A Cohen, Craig R Katabira, Elly Ronald, Allan Tumwesigye, Elioda Were, Edwin Fife, Kenneth H Kiarie, James Farquhar, Carey John-Stewart, Grace Kidoguchi, Lara Coombs, Robert W Hendrix, Craig Marzinke, Mark A Frenkel, Lisa Haberer, Jessica E Bangsberg, David Celum, Connie |
| author2Str |
Donnell, Deborah Mugo, Nelly R Ndase, Patrick Thomas, Katherine K Campbell, James D Wangisi, Jonathan Tappero, Jordan W Bukusi, Elizabeth A Cohen, Craig R Katabira, Elly Ronald, Allan Tumwesigye, Elioda Were, Edwin Fife, Kenneth H Kiarie, James Farquhar, Carey John-Stewart, Grace Kidoguchi, Lara Coombs, Robert W Hendrix, Craig Marzinke, Mark A Frenkel, Lisa Haberer, Jessica E Bangsberg, David Celum, Connie |
| ppnlink |
ELV013808834 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/S1473-3099(14)70937-5 |
| up_date |
2024-07-06T17:25:52.633Z |
| _version_ |
1803851401930997760 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV027904164</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623191754.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1473-3099(14)70937-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014004000028.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV027904164</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1473-3099(14)70937-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.44</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Baeten, Jared M</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Antiretroviral pre-exposure prophylaxis (PrEP), with daily oral tenofovir disoproxil fumarate or tenofovir disoproxil fumarate in combination with emtricitabine, has been shown to be efficacious for HIV-1 prevention. Although the use of more than one antiretroviral agent is essential for effective HIV-1 treatment, more than one agent might not be required for effective prophylaxis. We assessed the efficacy of single-agent tenofovir disoproxil fumarate relative to combination emtricitabine plus tenofovir disoproxil fumarate as PrEP.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Donnell, Deborah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mugo, Nelly R</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ndase, Patrick</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomas, Katherine K</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Campbell, James D</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wangisi, Jonathan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tappero, Jordan W</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bukusi, Elizabeth A</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohen, Craig R</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Katabira, Elly</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ronald, Allan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tumwesigye, Elioda</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Were, Edwin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fife, Kenneth H</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kiarie, James</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Farquhar, Carey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">John-Stewart, Grace</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kidoguchi, Lara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Coombs, Robert W</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hendrix, Craig</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marzinke, Mark A</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Frenkel, Lisa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Haberer, Jessica E</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bangsberg, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Celum, Connie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Berhane, S. ELSEVIER</subfield><subfield code="t">Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model</subfield><subfield code="d">2016</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV013808834</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:14</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:1055-1064</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1473-3099(14)70937-5</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.44</subfield><subfield code="j">Parasitologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">14</subfield><subfield code="j">2014</subfield><subfield code="e">11</subfield><subfield code="h">1055-1064</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.398903 |